Hypothalamic-pituitary-gonadal axis (HPG axis) (HPG axis)

The Hypothalamic-pituitary-gonadal (HPG) axis is a critical neuroendocrine system that coordinates reproductive development, the menstrual cycle, and gametogenesis in humans (StatPearls, 2023). This axis operates through a hierarchical signaling cascade where the hypothalamus secretes Gonadotropin-releasing hormone (GnRH) in pulses, stimulating the anterior pituitary to release Follicle-stimulating hormone (FSH) and Luteinizing hormone (LH) (NIH, 2022). These hormones then act on the gonads to produce sex steroids like estrogen and testosterone, which in turn provide essential feedback to the hypothalamus and pituitary to maintain physiological balance (Wikipedia, 2024). Clinically, the HPG axis serves as a primary therapeutic target for managing conditions such as infertility, polycystic ovary syndrome (PCOS), and hormone-dependent cancers like prostate and breast cancer (PubMed, 2021). Pharmacological interventions include GnRH analogs that can either desensitize or block pituitary receptors, as well as inhibitors of steroidogenic enzymes like aromatase (PubChem, 2023). Because the axis regulates systemic hormone levels, its manipulation can lead to significant side effects, including decreased bone density, metabolic changes, and vasomotor symptoms, requiring careful clinical oversight (Mayo Clinic, 2023).

Other names

Hypothalamic-pituitary-gonadal axisHPG axisHypothalamic-pituitary-ovarian axisHypothalamic-pituitary-testicular axisGonadal axisHPO axisHPT axis

The HPG axis is modulated through the administration of GnRH receptor agonists or antagonists to regulate pituitary gonadotropin release, or through the use of aromatase inhibitors and selective estrogen/androgen receptor modulators to interfere with steroid synthesis and feedback mechanisms (StatPearls, 2023; PubMed, 2021).